Speakers: 

Esther Mann, DO, Hematology/Oncology Fellow, Geisinger - has nothing to disclose.

Ryan Lozano, PharmD, PGY2 Hematology/Oncology Pharmacy Resident - has nothing to disclose.

Moderator: 

Tristan Maiers, PharmD, BCOP, PGY2 Oncology Residency Program Director, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Discuss the background of ALL including diagnosis, transplant indications, and transplant complications.
• Comprehend the pharmacology for treatment of ALL.
• Describe the impact of transplant in the ALL population. 

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Tristan Maiers, PharmD, BCOP; Rajiv Panikkar, MD; Michele Long, BSN; Jaime Weeder, NP and Christopher Kashi, PA-C have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None